Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Interest Expenses (2023 - 2025)

Biofrontera (BFRI) has 3 years of Interest Expenses data on record, last reported at $120000.0 in Q1 2025.

  • For Q1 2025, Interest Expenses fell 91.56% year-over-year to $120000.0; the TTM value through Sep 2025 reached $120000.0, down 91.61%, while the annual FY2024 figure was $2.1 million, 857.27% up from the prior year.
  • Interest Expenses reached $120000.0 in Q1 2025 per BFRI's latest filing, up from $9000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.4 million in Q1 2024 and bottomed at $9000.0 in Q3 2024.
  • Average Interest Expenses over 3 years is $398250.0, with a median of $81500.0 recorded in 2023.
  • Peak YoY movement for Interest Expenses: crashed 79.07% in 2024, then plummeted 91.56% in 2025.
  • A 3-year view of Interest Expenses shows it stood at $43000.0 in 2023, then plummeted by 79.07% to $9000.0 in 2024, then skyrocketed by 1233.33% to $120000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $120000.0 in Q1 2025, $9000.0 in Q3 2024, and $1.4 million in Q1 2024.